| 000 | 01118 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250513014156.0 | ||
| 264 | 0 | _c19810723 | |
| 008 | 198107s 0 0 eng d | ||
| 022 | _a0022-3565 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAbernethy, D R | |
| 245 | 0 | 0 |
_aAlterations in drug distribution and clearance due to obesity. _h[electronic resource] |
| 260 |
_bThe Journal of pharmacology and experimental therapeutics _cJun 1981 |
||
| 300 |
_a681-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntipyrine _xblood |
| 650 | 0 | 4 |
_aDiazepam _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMetabolic Clearance Rate |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aObesity _xmetabolism |
| 650 | 0 | 4 |
_aPharmaceutical Preparations _xmetabolism |
| 700 | 1 | _aGreenblatt, D J | |
| 700 | 1 | _aDivoll, M | |
| 700 | 1 | _aHarmatz, J S | |
| 700 | 1 | _aShader, R I | |
| 773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 217 _gno. 3 _gp. 681-5 |
|
| 999 |
_c7229520 _d7229520 |
||